Abstract
We describe a novel mutation identified in the antithrombin III (AT-III) propeptide responsible for AT-III deficiency. This mutation, a C to A transversion in exon 2, converts the cysteine at position -4 into a stop codon (TGC-->TGA). In this family with severe thrombophilia, the mutation co-segregates with the clinical phenotype.
MeSH terms
-
Adult
-
Antithrombin III / genetics*
-
Antithrombin III Deficiency
-
Disease Susceptibility
-
Exons / genetics
-
Female
-
Humans
-
Intracranial Embolism and Thrombosis / blood
-
Intracranial Embolism and Thrombosis / etiology*
-
Male
-
Pedigree
-
Point Mutation*
-
Polymerase Chain Reaction
-
Recurrence
-
Thrombophlebitis / blood
-
Thrombophlebitis / etiology*